Literature DB >> 20837540

Spontaneous Irs1 passenger mutation linked to a gene-targeted SerpinB2 allele.

Randal J Westrick1, Karen L Mohlke, Lindsey M Korepta, Angela Y Yang, Goujing Zhu, Sara L Manning, Mary E Winn, Kristiann M Dougherty, David Ginsburg.   

Abstract

In characterizing mice with targeted disruption of the SerpinB2 gene, we observed animals that were small at birth with delayed growth and decreased life expectancy. Although this phenotype cosegregated with homozygosity for the inactive SerpinB2 allele, analysis of homozygous SerpinB2-deficient mice derived from two additional independent embryonic stem (ES) cell clones exhibited no growth abnormalities. Examination of additional progeny from the original SerpinB2-deficient line revealed recombination between the small phenotype (smla) and the SerpinB2 locus. The locus responsible for smla was mapped to a 2.78-Mb interval approximately 30 Mb proximal to SerpinB2, bounded by markers D1Mit382 and D1Mit216. Sequencing of Irs1 identified a nonsense mutation at serine 57 (S57X), resulting in complete loss of IRS1 protein expression. Analysis of ES cell DNA suggests that the S57X Irs1 mutation arose spontaneously in an ES cell subclone during cell culture. Although the smla phenotype is similar to previously reported Irs1 alleles, mice exhibited decreased survival, in contrast to the enhanced longevity reported for IRS1 deficiency generated by gene targeting. This discrepancy could result from differences in strain background, unintended indirect effects of the gene targeting, or the minimal genetic interference of the S57X mutation compared with the conventionally targeted Irs1-KO allele. Spontaneous mutations arising during ES cell culture may be a frequent but underappreciated occurrence. When linked to a targeted allele, such mutations could lead to incorrect assignment of phenotype and may account for a subset of markedly discordant results from experiments independently targeting the same gene.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20837540      PMCID: PMC2947888          DOI: 10.1073/pnas.1012050107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

1.  Myf-5 revisited: loss of early myotome formation does not lead to a rib phenotype in homozygous Myf-5 mutant mice.

Authors:  A Kaul; M Köster; H Neuhaus; T Braun
Journal:  Cell       Date:  2000-07-07       Impact factor: 41.582

2.  Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2.

Authors:  Y Kido; D J Burks; D Withers; J C Bruning; C R Kahn; M F White; D Accili
Journal:  J Clin Invest       Date:  2000-01       Impact factor: 14.808

Review 3.  Insulin signaling pathways in time and space.

Authors:  Alan R Saltiel; Jeffrey E Pessin
Journal:  Trends Cell Biol       Date:  2002-02       Impact factor: 20.808

4.  Genetic modifiers of the insulin resistance phenotype in mice.

Authors:  Y Kido; N Philippe; A A Schäffer; D Accili
Journal:  Diabetes       Date:  2000-04       Impact factor: 9.461

5.  Analysis of genetic inheritance in a family quartet by whole-genome sequencing.

Authors:  Jared C Roach; Gustavo Glusman; Arian F A Smit; Chad D Huff; Robert Hubley; Paul T Shannon; Lee Rowen; Krishna P Pant; Nathan Goodman; Michael Bamshad; Jay Shendure; Radoje Drmanac; Lynn B Jorde; Leroy Hood; David J Galas
Journal:  Science       Date:  2010-03-10       Impact factor: 47.728

6.  Restored insulin-sensitivity in IRS-1-deficient mice treated by adenovirus-mediated gene therapy.

Authors:  K Ueki; T Yamauchi; H Tamemoto; K Tobe; R Yamamoto-Honda; Y Kaburagi; Y Akanuma; Y Yazaki; S Aizawa; R Nagai; T Kadowaki
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

7.  Bidirectional transcriptional activity of PGK-neomycin and unexpected embryonic lethality in heterozygote chimeric knockout mice.

Authors:  P C Scacheri; J S Crabtree; E A Novotny; L Garrett-Beal; A Chen; K A Edgemon; S J Marx; A M Spiegel; S C Chandrasekharappa; F S Collins
Journal:  Genesis       Date:  2001-08       Impact factor: 2.487

8.  Embryonic stem cells and somatic cells differ in mutation frequency and type.

Authors:  Rachel B Cervantes; James R Stringer; Changshun Shao; Jay A Tischfield; Peter J Stambrook
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

9.  Direct estimates of human per nucleotide mutation rates at 20 loci causing Mendelian diseases.

Authors:  Alexey S Kondrashov
Journal:  Hum Mutat       Date:  2003-01       Impact factor: 4.878

10.  A novel spontaneous mutation of Irs1 in mice results in hyperinsulinemia, reduced growth, low bone mass and impaired adipogenesis.

Authors:  Victoria E DeMambro; Masanobu Kawai; Thomas L Clemens; Keertik Fulzele; Jane A Maynard; Caralina Marín de Evsikova; Kenneth R Johnson; Ernesto Canalis; Wesley G Beamer; Clifford J Rosen; Leah Rae Donahue
Journal:  J Endocrinol       Date:  2009-12-23       Impact factor: 4.286

View more
  13 in total

1.  Mice deficient in LMAN1 exhibit FV and FVIII deficiencies and liver accumulation of α1-antitrypsin.

Authors:  Bin Zhang; Chunlei Zheng; Min Zhu; Jiayi Tao; Matthew P Vasievich; Andrea Baines; Jinoh Kim; Randy Schekman; Randal J Kaufman; David Ginsburg
Journal:  Blood       Date:  2011-07-27       Impact factor: 22.113

2.  PON3 knockout mice are susceptible to obesity, gallstone formation, and atherosclerosis.

Authors:  Diana M Shih; Janet M Yu; Laurent Vergnes; Nassim Dali-Youcef; Matthew D Champion; Asokan Devarajan; Peixiang Zhang; Lawrence W Castellani; David N Brindley; Carole Jamey; Johan Auwerx; Srinivasa T Reddy; David A Ford; Karen Reue; Aldons J Lusis
Journal:  FASEB J       Date:  2014-12-04       Impact factor: 5.191

3.  SEC23B is required for the maintenance of murine professional secretory tissues.

Authors:  Jiayi Tao; Min Zhu; He Wang; Solomon Afelik; Matthew P Vasievich; Xiao-Wei Chen; Guojing Zhu; Jan Jensen; David Ginsburg; Bin Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-28       Impact factor: 11.205

4.  Mammalian COPII coat component SEC24C is required for embryonic development in mice.

Authors:  Elizabeth J Adams; Xiao-Wei Chen; K Sue O'Shea; David Ginsburg
Journal:  J Biol Chem       Date:  2014-07-25       Impact factor: 5.157

5.  Palmoplantar Keratoderma in Slurp2-Deficient Mice.

Authors:  Christopher M Allan; Shiri Procaccia; Deanna Tran; Yiping Tu; Richard H Barnes; Mikael Larsson; Bernard B Allan; Lorraine C Young; Cynthia Hong; Peter Tontonoz; Loren G Fong; Stephen G Young; Anne P Beigneux
Journal:  J Invest Dermatol       Date:  2015-11-18       Impact factor: 8.551

6.  Altered phenotype in LMAN1-deficient mice with low levels of residual LMAN1 expression.

Authors:  Lesley A Everett; Rami N Khoriaty; Bin Zhang; David Ginsburg
Journal:  Blood Adv       Date:  2020-11-24

7.  Disruption of the Sec24d gene results in early embryonic lethality in the mouse.

Authors:  Andrea C Baines; Elizabeth J Adams; Bin Zhang; David Ginsburg
Journal:  PLoS One       Date:  2013-04-15       Impact factor: 3.240

8.  SEC24A deficiency lowers plasma cholesterol through reduced PCSK9 secretion.

Authors:  Xiao-Wei Chen; He Wang; Kanika Bajaj; Pengcheng Zhang; Zhuo-Xian Meng; Danjun Ma; Yongsheng Bai; Hui-Hui Liu; Elizabeth Adams; Andrea Baines; Genggeng Yu; Maureen A Sartor; Bin Zhang; Zhengping Yi; Jiandie Lin; Stephen G Young; Randy Schekman; David Ginsburg
Journal:  Elife       Date:  2013-04-09       Impact factor: 8.140

9.  Spontaneous 8bp Deletion in Nbeal2 Recapitulates the Gray Platelet Syndrome in Mice.

Authors:  Kärt Tomberg; Rami Khoriaty; Randal J Westrick; Heather E Fairfield; Laura G Reinholdt; Gary L Brodsky; Pavel Davizon-Castillo; David Ginsburg; Jorge Di Paola
Journal:  PLoS One       Date:  2016-03-07       Impact factor: 3.240

10.  Murine Surf4 is essential for early embryonic development.

Authors:  Brian T Emmer; Paul J Lascuna; Vi T Tang; Emilee N Kotnik; Thomas L Saunders; Rami Khoriaty; David Ginsburg
Journal:  PLoS One       Date:  2020-01-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.